Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
135.95
+1.55
+(1.15%)
At close: February 21 at 8:00:56 AM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
4,408,000
3,784,000
4,259,000
4,616,000
3,477,000
Investing Cash Flow
-2,868,000
-1,892,000
-2,743,000
-1,578,000
-1,340,000
Financing Cash Flow
-713,000
-1,732,000
-1,555,000
-2,504,000
-1,522,000
End Cash Position
3,192,000
1,982,000
1,854,000
1,899,000
1,355,000
Capital Expenditure
-2,258,000
-2,023,000
-1,806,000
-1,421,000
-1,563,000
Issuance of Debt
1,202,000
1,216,000
2,918,000
859,000
6,437,000
Repayment of Debt
-1,821,000
-1,784,000
-3,506,000
-2,606,000
-7,272,000
Free Cash Flow
2,150,000
1,761,000
2,453,000
3,195,000
1,914,000
12/31/2020 - 1/3/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EVT.VI Evotec SE
8.50
-0.82%
PLCN.CN Cannibble Food-Tech Ltd.
0.0200
-33.33%
BOI.PA Boiron SA
25.20
+1.00%
N4P.L N4 Pharma Plc
0.5750
0.00%
TEV.F Teva Pharmaceutical Industries Limited
16.10
-2.13%
MERK.JK PT Merck Tbk
3,460.00
+0.29%
MOB.ST Moberg Pharma AB (publ)
9.06
-0.06%
CINPHA.ST Cinclus Pharma Holding AB (publ)
16.00
+1.89%
SECARE.ST Swedencare AB (publ)
46.08
+0.88%
3320.HK China Resources Pharmaceutical Group Limited
5.480
+1.29%